+AA
Fr
Back
Evidence Summary

What is an Evidence Summary?

Key messages from scientific research that's ready to be acted on

Got It, Hide this
  • Rating:

There are mixed and uncertain outcomes associated with approaches to end-of-life dementia care that are based on established quality standards

Candy B, Elliott M, Moore K, et al.  UK quality statements on end of life care in dementia: A systematic review of research evidence BMC Palliative Care. 2015 October:14(51).

Review question

Do approaches to end-of-life care for dementia patients that meet quality standards established by the United Kingdom’s National Institute for Health and Care Excellence (NICE) improve the well-being of patients and their families?

Background

Patients with dementia require specialized palliative care due to the progressive, neurodegenerative nature of their disease. 

Initiatives such as the quality standards established by NICE exist to guide clinicians and policymakers to provide the most appropriate end-of-life care. These are based on evidence-based best practice guidelines.

No systematic efforts to evaluate the benefits of approaches to end-of-life care informed by NICE quality standards have been undertaken, and this study aims to determine if the approaches can lead to a meaningful impact on the well-being of dementia patients and their families.

How the review was done

A detailed search of a number of electronic databases for studies published between January 2001 and August 2014 was conducted, and studies were included if they focused on participants with moderate to advanced dementia, and on approaches to end-of-life dementia care that met the quality standards established by NICE.

A total of 5,548 studies were identified in searches, and seven were included in the review after assessments for eligibility.

This review was funded by Marie Curie Cancer Care.

What the researchers found

The review found studies that evaluated a number of different approaches, including personalized care plans, discussions of future care planning with caregivers during the early stages of dementia, and palliative-care assessments at later stages of the disease.  

Studies evaluating the impact of future care planning and palliative care assessments were limited, generally of low quality, and measured different outcomes. Thus, the overall benefits reported were mixed and no definitive conclusions can be drawn.

None of the included studies assessed the well-being and quality life of family members of the patient, adverse events, or economic costs associated with the intervention.

Conclusion

Due to the weak design and variation in outcome measures used by included studies, this review is unable to establish that approaches to end-of-life dementia care based on NICE quality standards benefit dementia patients and their families.




Related Evidence Summaries

Related Web Resources

  • Alzheimer's Disease: Do Ginkgo products help?

    Informed Health Online
    Gingko supplements (240 mg per day) may help reduce symptoms of Alzheimer's disease and enable you to perform daily tasks better. Be aware that gingko could interact with other medications, so talk to your doctor before taking any supplements.
  • Dementia in long-term care

    Canadian Institute for Health Information
    Older adults with dementia may need to move into long-term care homes if they can no longer stay at home. These people have higher risk of getting physically restrained or given antipsychotic medication. Changes to policy and education have made these things happen less often.
  • Statins

    Cognitive Vitality
    Research has shown that taking statins later in life will not prevent Alzheimer’s or dementia. Statins are used to manage cholesterol. Cholesterol management may lower your risk for getting Alzheimer’s disease as you get older.
DISCLAIMER These summaries are provided for informational purposes only. They are not a substitute for advice from your own health care professional. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the McMaster Optimal Aging Portal (info@mcmasteroptimalaging.org).

Register for free access to all Professional content

Register
Want the latest in aging research? Sign up for our email alerts.
Subscribe
© 2012 - 2019 McMaster University | 1280 Main Street West | Hamilton, Ontario L8S4L8 | +1 905-525-9140 | Terms Of Use